Floatz logo

PROPOFOL

Postoperative Pain, Chronic

University of CreteSmall moleculePhase 4 / ApprovedActive
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
89/ 100

Competitive context

19 Active assets in the Postoperative Pain, Chronic cohort.

Asset / SponsorPhaseRating
MAGNESIUM METALLICUM
University of Crete
Phase 4BB
CISATRACURIUM ION
University of Crete
Phase 4BB
DROPERIDOL
University of Crete
Phase 4BB
NEPENTHE
Esbjerg Hospital - University Hospital of Southern Denmark
Phase 4BB
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE
University of Crete
Phase 4BB

View all 19 →

Same molecule, other indications

PROPOFOL is also rated in:

Pain, ChronicDormant
BBB
Indicative ·
79 / 100
View asset →
headache disorderDormant
BBB
Indicative ·
73 / 100
View asset →
morbid obesityDormant
BBB
Indicative ·
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →